Implanet announced the first surgeries in the U.S. with JAZZ™ PF spinal system, the latest addition to its JAZZ® range.
JAZZ PF allows surgeons to create a soft landing of posterior spinal constructs to prevent proximal junctional kyphosis (PJK). This syndrome is a relatively common and serious complication following adult spinal deformity surgery. Studies show that up to 40% of patients who have undergone spinal deformity surgery develop PJK and may need to be reoperated.
Use of JAZZ PF creates a stiffness gradient between the upper instrumented vertebrae and the tethered proximal segmental level. The system requires no specific instrumentation.
CEO Ludovic Lastennet said, “JAZZ PF provides a response both to the issues surgeons face in degenerative disorders and to budgetary requirements placed on American healthcare facilities during this post-pandemic period. …For the first time, we have a universal solution that can be used in 25% to 30% of procedures.”
Implanet announced the first surgeries in the U.S. with JAZZ™ PF spinal system, the latest addition to its JAZZ® range.
JAZZ PF allows surgeons to create a soft landing of posterior spinal constructs to prevent proximal junctional kyphosis (PJK). This syndrome is a relatively common and serious complication following adult spinal deformity...
Implanet announced the first surgeries in the U.S. with JAZZ™ PF spinal system, the latest addition to its JAZZ® range.
JAZZ PF allows surgeons to create a soft landing of posterior spinal constructs to prevent proximal junctional kyphosis (PJK). This syndrome is a relatively common and serious complication following adult spinal deformity surgery. Studies show that up to 40% of patients who have undergone spinal deformity surgery develop PJK and may need to be reoperated.
Use of JAZZ PF creates a stiffness gradient between the upper instrumented vertebrae and the tethered proximal segmental level. The system requires no specific instrumentation.
CEO Ludovic Lastennet said, “JAZZ PF provides a response both to the issues surgeons face in degenerative disorders and to budgetary requirements placed on American healthcare facilities during this post-pandemic period. …For the first time, we have a universal solution that can be used in 25% to 30% of procedures.”
Copy to clipboard 
